Drugs / Quadrivalent human papillomavirus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT00339040 Comparator | Oct 2006 → Aug 2009 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| — | NCT01184079 Comparator | Oct 2010 → May 2012 | — | University of Pittsburgh | Completed | No outcome recorded |
| — | NCT00572832 Comparator | Sep 2007 → Apr 2009 | human papilloma virus infection | University of Pittsburgh | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quadrivalent human papillomavirus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00339040 ↗ |
| Modality | Vaccine | “new human papillomavirus (HPV) vaccine” NCT00339040 ↗ |